Association of tumour mutational burden (TMB) with outcomes in stage IIIA(N2) non-small cell lung cancer (NSCLC) patients treated with neoadjuvant chemotherapy and durvalumab: prospective analysis of the multicenter single-arm phase II trial SAKK16/14

I Alborelli, P. M. Jermann, K. Leonards, M. Manzo,E. Keller,A. Zippelius, E. Eboulet, D. Betticher, M. Frueh, C. Britschgi,S. Peters,M. Mark,A. F. Ochsenbein, W. -D Janthur, C. Waibel, N. Mach, P. Froesch, M. Pless,Savic S. Prince,S. Rothschild

ONCOLOGY RESEARCH AND TREATMENT（2021）

Cited 0|Views6

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined